Anwar M Hashem Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB Health canada Biography Publications Institution JoVE Articles Anwar M Hashem has not added a biography. If you are Anwar M Hashem and would like to personalize this page please email our Author Liaison for assistance. Publications Die Wirkung Von Interferon-α über Die Expression Des Cytochrom P450 3A4 in Menschlichen Berechnete Zellen Toxicology and Applied Pharmacology. Jun, 2011 | Pubmed ID: 21466820 Universal-Antikörper Gegen Das Stark Konservierten Grippe-Fusion-Peptid Kreuz-mehrere Subtypen Des Influenza-A-Virus Zu Neutralisieren Biochemical and Biophysical Research Communications. Dec, 2010 | Pubmed ID: 21078301 Qualitative Und Quantitative Analysen Der Praktisch Alle Subtypen Der Grippe A Und B Virale Neuraminidasen Unter Verwendung Der Antikörper, Die Gezielt Der Universell Konservierten Sequenzen Vaccine. Aug, 2010 | Pubmed ID: 20621113 Aurintricarboxylic Säure Ist Ein Potenter Inhibitor Der Influenza-A- Und B Virus Neuraminidasen PloS One. 2009 | Pubmed ID: 20020057 Quantitative Analysen aller Influenza Typ A Viral Hämagglutininen und Neuraminidasen mit Universal Antikörper in Einfache Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection
Quantitative Analysen aller Influenza Typ A Viral Hämagglutininen und Neuraminidasen mit Universal Antikörper in Einfache Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection